Breathe Well Live Well
|
Asmacure Ltee to Present at the 2011 BIO Business Forum During the Annual BIO …
PR Newswire (press release) QUEBEC CITY, June 22, 2011 /PRNewswire/ — Asmacure Ltee, a clinical-stage biopharmaceutical company focused on the development of nicotinic receptor agonists for the treatment of asthma and other inflammatory diseases, announced today that CEO Martin … |
View full post on asthma – Google News
|
Theron Pharmaceuticals to Present at the American Thoracic Society Conference …
SunHerald.com Headquartered in Sunnyvale, California, Theron Pharmaceuticals is committed to developing improved treatments for COPD and asthma. COPD is a slowly developing progressive small airways disease comprised broadly of chronic bronchitis and emphysema, … Theron Pharmaceuticals to Present at the American Thoracic Society Conference … |
View full post on asthma – Google News
 CTV.ca |
NL bans smoking in cars while children present
CTV.ca Health Minister Jerome Kennedy says children who breathe in second-hand smoke are more likely to suffer health problems, such as asthma, bronchitis and middle ear infections. The government previously banned smoking in bars, bingo halls, … |
View full post on asthma – Google News
|
NL bans smoking in cars while children present, workplace smoking rooms
Winnipeg Free Press Health Minister Jerome Kennedy says children who breathe in second-hand smoke are more likely to suffer health problems, such as asthma, bronchitis and middle ear infections. The government previously banned smoking in bars, bingo halls, … |
View full post on asthma – Google News
|
Revalesio to Present Research on the Anti-Inflammatory Effects of RNS60 in Asthma
Genetic Engineering News Revalesio Corporation announced today that research related to the use of RNS60, its novel anti-inflammatory, will be featured in two poster presentations at the Annual Meeting of the American Academy of Allergy Asthma and Immunology (AAAAI) in San … |
View full post on asthma – Google News
|
Theron Pharmaceuticals to Present at the BIO-Europe Spring Conference on March …
Business Wire (press release) Dr. Zhang will provide a company overview and highlight Theron's lead COPD/asthma candidate, TRN-157, for which the company is actively seeking Biopharma partners on a global or regional basis to maximize its broad therapeutic potential in these … |
View full post on asthma – Google News
|
MediciNova to Present at the Rodman and Renshaw Annual Global Investment …
MarketWatch (press release) MediciNova's pipeline includes six clinical-stage compounds for the treatment of acute exacerbations of asthma, COPD exacerbations, multiple sclerosis and … |
View full post on asthma – Google News